Dental Implants in Rheumatoid Arthritis Patients
Yes, dental implant surgery can be safely performed in patients with rheumatoid arthritis on DMARDs, biologics, and low-dose glucocorticoids, but specific perioperative medication management is essential to minimize infection risk while preventing disease flare.
Medication Management Strategy
While the available evidence specifically addresses total joint arthroplasty rather than dental implants 1, the principles of perioperative management can be extrapolated to dental implant surgery given similar infection concerns. The 2022 ACR/AAHKS guidelines provide the most comprehensive framework:
Pre-operative Medication Adjustments
Conventional DMARDs (Continue Through Surgery):
- Methotrexate, leflunomide, hydroxychloroquine, sulfasalazine should be continued without interruption 1
- These medications do not significantly increase postoperative infection risk and stopping them risks disease flare
- Exception: Consider withholding in patients with history of severe/recurrent infections or prior prosthetic joint infections 1
Biologic Agents (Withhold Temporarily):
- Plan dental implant surgery when the next biologic dose is due (at the end of the dosing cycle) 1
- For example: if patient receives adalimumab every 2 weeks, schedule surgery for week 3; if rituximab every 6 months, schedule during month 7 1
- This timing allows drug levels to be at their lowest while minimizing interruption duration
- Recent evidence suggests prolonged withholding does not substantially reduce infection risk beyond one dosing interval 2
JAK Inhibitors (Brief Hold):
- Withhold tofacitinib, baricitinib, and upadacitinib for at least 3 days prior to surgery 1
Glucocorticoids (Continue Current Dose):
- Continue the patient's current daily glucocorticoid dose rather than increasing to stress doses 1
- Critical caveat: Glucocorticoids are the most consistent risk factor for postoperative infection 2, 3
- Minimize glucocorticoid dose before surgery if medically feasible
- Low-dose glucocorticoids (≤5 mg/day prednisone equivalent) carry lower risk but still require vigilance
Post-operative Medication Resumption
Resume antirheumatic therapy when 1:
- Wound shows evidence of healing
- Sutures/staples are removed
- No significant swelling, erythema, or drainage present
- No ongoing infection at any site
- Typically around 14 days post-operatively
Additional Risk Stratification
The following factors increase infection risk and warrant heightened precautions 3:
- Alcohol abuse
- Diabetes mellitus
- Obesity
- Tobacco use
- Higher glucocorticoid doses
Pre-operative Optimization
Before proceeding with dental implant surgery 4:
- Achieve healthy periodontal status - RA patients have increased periodontitis risk
- Consider antibiotic prophylaxis - coordinate with rheumatologist
- Assess salivary function - RA commonly causes decreased secretion
- Optimize disease control - surgery should ideally occur during low disease activity
Important Clinical Considerations
The evidence base has important limitations: All guideline recommendations are conditional with low-to-moderate quality evidence 1. The guidelines specifically address major orthopedic surgery (hip/knee arthroplasty), not dental procedures. However, dental implants involve bone integration and carry infection risk similar to prosthetic joint surgery, making these principles applicable.
Balancing competing risks: The decision involves weighing infection risk from immunosuppression against disease flare risk from medication interruption 5, 2. Recent data suggests that brief, strategic medication holds (one dosing interval for biologics) provide optimal balance 1, 2.
Biologic therapy and infection risk: While biologics theoretically increase infection risk, recent studies suggest this may be confounded by disease severity and comorbidities rather than the medications themselves 2, 3. Nonetheless, a brief hold remains prudent.
RA as relative contraindication: The literature describes RA as a relative contraindication for dental implants due to decreased bone regenerative potential, frequent periodontitis, and medication effects 4. However, with proper preparation and medication management, procedures can be performed safely - patients must understand the higher failure risk.
Coordination of care: Close communication between the oral surgeon and rheumatologist is essential for optimizing timing and medication management while maintaining disease control.